RJA
LFVN icon

Raymond James & Associates’s LifeVantage LFVN Stock Holding History

Raymond James & Associates’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,938
Closed -$342K – 3703
2019
Q1 		$342K Buy
23,938
+10,718
+81% +$156K ﹤0.01% 2908
2018
Q4 		$174K Buy
+13,220
New +$158K ﹤0.01% 3186

Other funds holding LFVN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Raymond James & Associates's LFVN Position: Q2 2019 in Review

Raymond James & Associates sold out of LifeVantage (LFVN) in Q2 2019, closing a stake of 23,938 shares — an estimated $342K sold.

Raymond James & Associates first reported a position in LFVN in Q4 2018 and held it in 2 quarters. The position peaked at $342K in Q1 2019. 79 funds tracked by Wall St. Rank hold LFVN as of Q2 2019.

  • Raymond James & Associates reported no remaining LifeVantage position as of Q2 2019 after selling out during the quarter.
  • Raymond James & Associates sold 23,938 LifeVantage shares in Q2 2019, an estimated $342K.
  • Raymond James & Associates first reported a position in LifeVantage in Q4 2018 and held it in 2 quarters.
  • Raymond James & Associates's LifeVantage position peaked at $342K in Q1 2019.
  • 79 funds tracked by Wall St. Rank held LifeVantage as of Q2 2019.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.